Home / Companies / Athira Pharma Inc / Trends
Athira Pharma Inc H-1B trends
Quarterly LCA aggregate trend points for Athira Pharma Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Athira Pharma Inc span 2023 Q3 to 2025 Q1, peaking at 1 filings in 2023 Q3.
The most recent reported period (2025 Q1) shows 1 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2023 Q3 | 1 | 1 | 1 | $94,000 | $93,018 | 1 | 100.0% |
| 2023 Q4 | 1 | 1 | 1 | $94,000 | $76,294 | 1 | 100.0% |
| 2025 Q1 | 1 | 1 | 1 | $94,000 | $76,294 | 1 | 100.0% |
Frequently asked questions
- How have H-1B filings for Athira Pharma Inc changed over time?
- H-1B LCA filings for Athira Pharma Inc span 2023 Q3 to 2025 Q1, peaking at 1 filings in 2023 Q3. The most recent reported period (2025 Q1) shows 1 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=athira+pharma+inc&metric=lca_countJSON